Paroxysmal tachycardia-related age-adjusted mortality rates per 100,000, stratified by census regions in adults in the United States, 1999 to 2020. by Aman Goyal (19231397)

Subjects:

Paroxysmal tachycardia-related age-adjusted mortality rates per 100,000, stratified by race in adults in the United States, 1999 to 2020. by Aman Goyal (19231397)

Subjects:

Paroxysmal tachycardia-related age-adjusted mortality rates per 100,000, stratified by age groups in adults in the United States, 1999 to 2020. by Aman Goyal (19231397)

Subjects:

Paroxysmal tachycardia-related deaths and age-adjusted mortality rates per 100,000, stratified by state in adults in the United States, 1999 to 2020. by Aman Goyal (19231397)

Subjects:

The Laboratory Animal Flow Diagram. by Xueqin lu (22250795)

Subjects:

¹H NMR spectra for kylo-0603. by Xueqin lu (22250795)

Subjects:

¹³C NMR spectra for Kylo-0603. by Xueqin lu (22250795)

Subjects:

The structures of T3 and Kylo-0603. by Xueqin lu (22250795)

Subjects:

Synthesis process of Kylo-0603. by Xueqin lu (22250795)

Subjects:

ESI-HRMS spectra for Kylo-0603. by Xueqin lu (22250795)

Subjects:

SARS-CoV-2 inhibits SG formation and decreases expression of G3BP1. by Stacia M. Dolliver (13822801)

Average annual change, 95% confidence interval and significance for sum concentrations of different compound groups. by Matti Viluksela (321291)

Results of GO analysis showing significantly enriched biological process (BP), cellular component (CC) and molecular function (MF) in genes with significantly decreased expression... by Lucy Granat (5570813)

Supplementary Material for: Enhanced Recovery after Surgery for Radical Cystectomy Decreases Postoperative Complications at Different Times by Lannes F. (11465377)

“…Mean length of stay did not differ significantly between ERAS and non-ERAS groups (12.7 ± 6.2 and 13.1 ± 5.7 days, respectively; <i>p</i> = 0.743). …”

Participant inclusion flowchart. by Shakila Meshkat (12360623)

Subjects:

Demographics of study sample. by Shakila Meshkat (12360623)

Subjects:

Unadjusted and adjusted ORs for associations between depressive symptoms and FS (depressive symptoms, PHQ-9 total score). by Shakila Meshkat (12360623)

Subjects:

Unadjusted and adjusted ORs from logistic regression for the associations between depressive symptoms and FS, subgrouped by ethnicity and PIR. by Shakila Meshkat (12360623)

Subjects:

Unadjusted and adjusted ORs for associations between depressive symptoms and FS cognitive-affective/somatic scores. by Shakila Meshkat (12360623)

Subjects:

Homozygous deletion of the orthologous murine <i>Ikzf1</i> enhancer results in significantly decreased <i>Ikzf1</i> expression, increased cell proliferation, and altered B cell dif... by Vincent U. Gant (9955199)